Top Story
PharmExec's Emerging Pharma Leaders 2015
2015's Emerging Pharma Leaders – selected by PharmExec's editorial staff with support from the Editorial Advisory Board – add to a list of more than 200 alumni dating back to June 2008. That first cohort of leaders was called “the change generation” and the description remains apt today. What is different is a greater diversity in leader backgrounds and the skills required to advance to the “c-suite”
...Read more

Emerging Pharma Leaders — Slide Show
If you're pressed for time and want just the names and faces, click here for a slide show of PharmExec's 17 Emerging Pharma Leaders 2015
...Read more

The Human Chain
Amid the release PharmExec's Emerging Pharma Leaders 2015, William Looney considers what will determine true leadership in big Pharma in the years ahead
...Read more

Biopharma
The Challenge of Forecasting Biosimilars
The landscape for biologics will change dramatically in the next decade. Biosimilars will generate many challenges for the forecaster, who must capture the dynamics that operate in these markets and do justice to the uncertainty of assumptions. Arthur G. Cook reports
...Read more

M&A
The Salix-Valeant Acquisition: “It's Just a Game”
Sarah Chaney gives an in-depth look at the Salix-Valeant acquisition — how analysts and investors can affect decision-making and potentially drive poor behavior
...Read more

Report
Pharma's Trillion-Dollar Sales Trophy: Will Payers Pony Up?
A combination of factors – strong science, internal asset management efficiencies, risk tolerant regulators and willing patients – are pushing the biopharma business toward a fresh landmark: $1 trillion in global sales by 2020. That's the finding from market analytics firm EvaluatePharma’s “World Preview 2015 – Outlook to 2020“. William Looney looks at the report's predictions
...Read more

//Carbylan Therapeutics (Palo Alto, CA) announced that Dr. Prem Ramiya has joined the Company as Vice President, Pharmaceutical Development & Supply Chain. //Onconova Therapeutics (Newtown, PA) appointed James J. Marino J.D., MBA, to its Board of Directors. //Evofem (San Diego, CA) named Russell Barrans as Vice President of Sales and Marketing for North America. //Ipsos appointed Jim Meyer, former CEO of Ipsos ASI in North America, to the newly created position of Chief Marketing Officer. Meyer will be responsible for developing and implementing marketing strategy to accelerate the transformation of Ipsos within the U.S. and Canada. //Advaxis (Princeton, NJ) appointed Shelonitda S. Rose, M.D., as Vice President, Clinical Development. //